![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. Show more
The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive activity and stealthing features that may further augment the...
CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a preclinical-stage biopharmaceutical company, committed to realizing the...
Eterna reports the development of an mRNA-engineered iPSC line developed using UltraSlice™ to express a B2M-HLA-E fusion transgene in lieu of the endogenous B2M gene product to mimic native B2M...
CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.145 | 8.50439882698 | 1.705 | 1.92 | 1.7 | 3221 | 1.78902914 | CS |
4 | 0.06 | 3.35195530726 | 1.79 | 1.95 | 1.6 | 6333 | 1.76808362 | CS |
12 | -0.37 | -16.6666666667 | 2.22 | 2.625 | 1.6 | 7755 | 1.90368487 | CS |
26 | 0.33 | 21.7105263158 | 1.52 | 2.625 | 1.43 | 8571 | 2.00871809 | CS |
52 | -0.45 | -19.5652173913 | 2.3 | 2.625 | 0.840101 | 15360 | 1.65469622 | CS |
156 | -2.35 | -55.9523809524 | 4.2 | 7.15 | 0.840101 | 32678 | 3.66624514 | CS |
260 | -2.35 | -55.9523809524 | 4.2 | 7.15 | 0.840101 | 32678 | 3.66624514 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions